Breaking
● GLP-1 trial shows 34% reduction in cardiovascular events over 5 years ● Senolytics drug enters Phase III — first human trial results expected Q1 2027 ● FDA fast-tracks CRISPR base-editing therapy for sickle cell disease ● Longevity biotech index up 12% YTD as institutional capital accelerates ● AI diagnostic platform achieves 97.2% accuracy in early-stage pancreatic cancer detection ● Harvard study links CGM use to 23% lower all-cause mortality in non-diabetics
Impact Health Magazine
Impact Health Summit conference
Events & Galas

Where the Health Elite Convenes

Invitation-only summits, intimate dinners, and city-based gatherings connecting the world's most influential voices in health, longevity, and wellness.

"The most valuable conversations in health are not happening in journals. They are happening over dinner between the people who are actually changing the world."
Impact Health Founder